DOI:
10.1055/s-00034913
Phlebologie
LinksClose Window
References
Buller HR, Lensing AW, Prins MH. et al.
A doseranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study.
Blood 2008;
112: 2242-2247.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.